Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Vaccination for Negative Conversion Time of Nucleic Acid in Nonsevere COVID-19 Patients Infected by SARS-CoV-2 Omicron Variant

Table 1

Clinical characteristics and laboratory findings of nonsevere COVID-19 patients infected by the SARS-CoV-2 Omicron variant.

Variables	Total (N = 226)
Age (years)	61 (48–70)
Age ≥ 65 years	95 (42.0%)
Male	127 (56.2%)
Comorbidities ≥ 1	84 (37.2%)
Hypertension	70 (31.0%)
Diabetes	30 (13.3%)
Cerebro-cardiovascular diseases	6 (2.7%)
Chronic respiratory diseases	5 (2.2%)
Chronic kidney disease	7 (3.1%)
Vaccinated ≥ 1 dose	145 (64.2%)
1 dose	6 (2.7%)
2 doses	72 (31.9%)
3 doses	67 (29.6%)
Moderate illness	49 (21.7%)
Leukocyte count, ×10^9 cells/L	5.38 (4.23–6.45)
Lymphopenia (<1.1 × 10^9 cells/L)	64 (28.3%)
Neutrophilia (>6.3 × 10^9 cells/L)	10 (4.4%)
Platelet count, ×10^9 cells/L	194 (157–244)
Hemoglobin, g/L	133 (119–146)
Low eosinophil level (<0.02 × 10^9 cells/L)	38 (16.8%)
Monocytosis (>0.6 × 10^9 cells/L)	48 (21.2%)
ALT, U/L	19 (13–27)
AST, U/L	22 (18–27)
Serum creatinine, umol/L	69 (58–78)
D-dimer, μg/mL	0.44 (0.32–0.65)
NLR	2.06 (1.47–3.04)

Data are presented as median (interquartile range (IQR), 25%–75%) for continuous variables and as number with percentage for categorical variables. ALT: alanine aminotransferase; AST: aspartate aminotransferase; NLR: neutrophil-to-lymphocyte ratio.